annual EBITDA:
-$35.57M+$113.56M(+76.15%)Summary
- As of today (May 29, 2025), AVDL annual EBITDA is -$35.57 million, with the most recent change of +$113.56 million (+76.15%) on December 31, 2024.
- During the last 3 years, AVDL annual EBITDA has risen by +$46.82 million (+56.83%).
- AVDL annual EBITDA is now -136.07% below its all-time high of $98.59 million, reached on December 31, 2017.
Performance
AVDL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$1.78M-$186.00K(-11.68%)Summary
- As of today (May 29, 2025), AVDL quarterly EBITDA is -$1.78 million, with the most recent change of -$186.00 thousand (-11.68%) on March 31, 2025.
- Over the past year, AVDL quarterly EBITDA has increased by +$22.34 million (+92.62%).
- AVDL quarterly EBITDA is now -104.46% below its all-time high of $39.92 million, reached on June 30, 2020.
Performance
AVDL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$13.23M+$22.34M(+62.80%)Summary
- As of today (May 29, 2025), AVDL TTM EBITDA is -$13.23 million, with the most recent change of +$22.34 million (+62.80%) on March 31, 2025.
- Over the past year, AVDL TTM EBITDA has increased by +$132.47 million (+90.92%).
- AVDL TTM EBITDA is now -110.75% below its all-time high of $123.11 million, reached on September 30, 2017.
Performance
AVDL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVDL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.2% | +92.6% | +90.9% |
| 3 y3 years | +56.8% | +93.8% | +86.3% |
| 5 y5 years | -50.6% | +73.6% | +35.1% |
AVDL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.2% | -235.0% | +97.1% | at high | +91.1% |
| 5 y | 5-year | -470.4% | +76.2% | -104.5% | +97.1% | -158.6% | +91.1% |
| alltime | all time | -136.1% | +76.2% | -104.5% | +97.6% | -110.8% | +91.1% |
AVDL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.78M(+11.7%) | -$13.23M(-62.8%) |
| Dec 2024 | -$35.57M(-76.1%) | -$1.59M(-220.9%) | -$35.57M(-41.2%) |
| Sep 2024 | - | $1.32M(-111.8%) | -$60.51M(-36.6%) |
| Jun 2024 | - | -$11.18M(-53.6%) | -$95.44M(-34.5%) |
| Mar 2024 | - | -$24.12M(-9.1%) | -$145.71M(-2.3%) |
| Dec 2023 | -$149.13M(+52.8%) | -$26.53M(-21.1%) | -$149.11M(+2.1%) |
| Sep 2023 | - | -$33.61M(-45.3%) | -$146.10M(+13.6%) |
| Jun 2023 | - | -$61.45M(+123.3%) | -$128.60M(+33.1%) |
| Mar 2023 | - | -$27.52M(+17.0%) | -$96.65M(-1.0%) |
| Dec 2022 | -$97.60M(+18.5%) | -$23.52M(+46.0%) | -$97.60M(+1.3%) |
| Sep 2022 | - | -$16.11M(-45.4%) | -$96.37M(-8.4%) |
| Jun 2022 | - | -$29.50M(+3.6%) | -$105.23M(+8.5%) |
| Mar 2022 | - | -$28.47M(+27.7%) | -$96.95M(+17.7%) |
| Dec 2021 | -$82.39M(-958.0%) | -$22.29M(-10.8%) | -$82.39M(+16.8%) |
| Sep 2021 | - | -$24.98M(+17.7%) | -$70.53M(+20.1%) |
| Jun 2021 | - | -$21.22M(+52.6%) | -$58.71M(-2520.2%) |
| Mar 2021 | - | -$13.90M(+33.3%) | $2.43M(-74.7%) |
| Dec 2020 | $9.60M(-140.7%) | -$10.43M(-20.8%) | $9.60M(-21.8%) |
| Sep 2020 | - | -$13.16M(-133.0%) | $12.28M(-45.6%) |
| Jun 2020 | - | $39.92M(-693.3%) | $22.56M(-210.7%) |
| Mar 2020 | - | -$6.73M(-13.2%) | -$20.38M(-13.7%) |
| Dec 2019 | -$23.61M(-75.2%) | -$7.75M(+169.2%) | -$23.61M(-73.6%) |
| Sep 2019 | - | -$2.88M(-4.8%) | -$89.41M(-8.9%) |
| Jun 2019 | - | -$3.02M(-69.7%) | -$98.17M(+4.3%) |
| Mar 2019 | - | -$9.96M(-86.5%) | -$94.13M(-1.1%) |
| Dec 2018 | -$95.14M(-196.5%) | -$73.54M(+531.4%) | -$95.14M(+283.5%) |
| Sep 2018 | - | -$11.65M(-1236.3%) | -$24.81M(-257.4%) |
| Jun 2018 | - | $1.02M(-109.3%) | $15.76M(-69.7%) |
| Mar 2018 | - | -$10.98M(+242.7%) | $52.06M(-47.2%) |
| Dec 2017 | $98.59M(+1619.5%) | -$3.20M(-111.1%) | $98.59M(-19.9%) |
| Sep 2017 | - | $28.92M(-22.5%) | $123.11M(+50.5%) |
| Jun 2017 | - | $37.33M(+5.0%) | $81.79M(+126.3%) |
| Mar 2017 | - | $35.55M(+66.8%) | $36.14M(+526.3%) |
| Dec 2016 | $5.73M(-93.7%) | $21.31M(-271.8%) | $5.77M(-159.5%) |
| Sep 2016 | - | -$12.40M(+49.1%) | -$9.70M(-126.7%) |
| Jun 2016 | - | -$8.32M(-260.5%) | $36.27M(-8.2%) |
| Mar 2016 | - | $5.18M(-11.3%) | $39.51M(-34.1%) |
| Dec 2015 | $90.84M(-229.3%) | $5.84M(-82.6%) | $59.97M(+135.1%) |
| Sep 2015 | - | $33.56M(-760.7%) | $25.50M(-292.8%) |
| Jun 2015 | - | -$5.08M(-119.8%) | -$13.23M(-43.7%) |
| Mar 2015 | - | $25.64M(-189.6%) | -$23.49M(-66.2%) |
| Dec 2014 | -$70.24M(+40.2%) | -$28.62M(+454.0%) | -$69.51M(+62.9%) |
| Sep 2014 | - | -$5.17M(-66.3%) | -$42.67M(-2.2%) |
| Jun 2014 | - | -$15.34M(-24.8%) | -$43.64M(-29.0%) |
| Mar 2014 | - | -$20.39M(+1047.2%) | -$61.44M(+22.6%) |
| Dec 2013 | -$50.10M(+712.2%) | -$1.78M(-71.0%) | -$50.10M(+12.6%) |
| Sep 2013 | - | -$6.14M(-81.5%) | -$44.50M(+1.1%) |
| Jun 2013 | - | -$33.15M(+266.6%) | -$44.02M(+175.7%) |
| Mar 2013 | - | -$9.04M(-336.6%) | -$15.97M(+40.7%) |
| Dec 2012 | -$6.17M(+19.5%) | $3.82M(-167.5%) | -$11.35M(-27.6%) |
| Sep 2012 | - | -$5.66M(+11.2%) | -$15.68M(+94.5%) |
| Jun 2012 | - | -$5.09M(+15.2%) | -$8.06M(+41.0%) |
| Mar 2012 | - | -$4.42M(+759.5%) | -$5.72M(+10.7%) |
| Dec 2011 | -$5.16M(+27.6%) | -$514.00K(-126.3%) | -$5.16M(+1441.2%) |
| Sep 2011 | - | $1.96M(-171.3%) | -$335.00K(-92.2%) |
| Jun 2011 | - | -$2.74M(-29.0%) | -$4.28M(-16.6%) |
| Mar 2011 | - | -$3.86M(-189.5%) | -$5.13M(+26.7%) |
| Dec 2010 | -$4.05M | $4.31M(-317.3%) | -$4.05M(-66.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$1.99M(-44.7%) | -$12.05M(-1.9%) |
| Jun 2010 | - | -$3.59M(+29.1%) | -$12.28M(+13.5%) |
| Mar 2010 | - | -$2.78M(-24.5%) | -$10.82M(+99.6%) |
| Dec 2009 | -$5.42M(+25.6%) | -$3.69M(+65.9%) | -$5.42M(-248.3%) |
| Sep 2009 | - | -$2.22M(+4.3%) | $3.66M(+21.6%) |
| Jun 2009 | - | -$2.13M(-181.4%) | $3.01M(+94.5%) |
| Mar 2009 | - | $2.62M(-51.5%) | $1.55M(-135.8%) |
| Dec 2008 | -$4.32M(-87.5%) | $5.39M(-287.8%) | -$4.32M(-73.2%) |
| Sep 2008 | - | -$2.87M(-20.0%) | -$16.10M(-23.2%) |
| Jun 2008 | - | -$3.59M(+10.6%) | -$20.97M(-29.8%) |
| Mar 2008 | - | -$3.25M(-49.2%) | -$29.86M(-13.8%) |
| Dec 2007 | -$34.65M(+4.4%) | -$6.39M(-17.4%) | -$34.65M(-0.4%) |
| Sep 2007 | - | -$7.74M(-38.0%) | -$34.80M(-4.4%) |
| Jun 2007 | - | -$12.48M(+55.2%) | -$36.42M(+12.5%) |
| Mar 2007 | - | -$8.04M(+22.8%) | -$32.38M(-2.5%) |
| Dec 2006 | -$33.20M(-7.8%) | -$6.55M(-30.0%) | -$33.20M(-9.1%) |
| Sep 2006 | - | -$9.36M(+10.9%) | -$36.54M(-4.1%) |
| Jun 2006 | - | -$8.43M(-4.9%) | -$38.10M(-0.2%) |
| Mar 2006 | - | -$8.86M(-10.3%) | -$38.18M(+6.0%) |
| Dec 2005 | -$36.03M(-417.0%) | -$9.88M(-9.5%) | -$36.02M(+77.8%) |
| Sep 2005 | - | -$10.92M(+28.3%) | -$20.26M(+210.7%) |
| Jun 2005 | - | -$8.51M(+26.9%) | -$6.52M(-2505.9%) |
| Mar 2005 | - | -$6.71M(-214.0%) | $271.00K(-97.6%) |
| Dec 2004 | $11.37M(-480.5%) | $5.88M(+108.8%) | $11.37M(+87.8%) |
| Sep 2004 | - | $2.82M(-263.8%) | $6.05M(+305.3%) |
| Jun 2004 | - | -$1.72M(-139.2%) | $1.49M(-7.7%) |
| Mar 2004 | - | $4.39M(+672.2%) | $1.62M(-134.2%) |
| Dec 2003 | -$2.99M(-341.5%) | $568.00K(-132.6%) | -$4.73M(-42.9%) |
| Sep 2003 | - | -$1.74M(+9.1%) | -$8.28M(+91.9%) |
| Jun 2003 | - | -$1.60M(-18.5%) | -$4.31M(-288.9%) |
| Mar 2003 | - | -$1.96M(-34.3%) | $2.28M(-74.1%) |
| Dec 2002 | $1.24M(-165.6%) | -$2.98M(-234.1%) | $8.80M(+8529.4%) |
| Sep 2002 | - | $2.22M(-55.5%) | $102.00K(-79.8%) |
| Jun 2002 | - | $5.00M(+9.6%) | $504.00K(-124.4%) |
| Mar 2002 | - | $4.56M(-139.0%) | -$2.06M(-34.6%) |
| Dec 2001 | -$1.89M(-87.4%) | -$11.68M(-545.0%) | -$3.15M(-79.8%) |
| Sep 2001 | - | $2.63M(+7.9%) | -$15.58M(+2.5%) |
| Jun 2001 | - | $2.43M(-29.8%) | -$15.21M(+2.8%) |
| Mar 2001 | - | $3.47M(-114.4%) | -$14.80M(-9.1%) |
| Dec 2000 | -$14.99M(+158.8%) | -$24.11M(-903.6%) | -$16.28M(+407.6%) |
| Sep 2000 | - | $3.00M(+5.6%) | -$3.21M(-29.0%) |
| Jun 2000 | - | $2.84M(+43.4%) | -$4.52M(-28.4%) |
| Mar 2000 | - | $1.98M(-118.0%) | -$6.32M(-9.7%) |
| Dec 1999 | -$5.79M(-29.8%) | -$11.03M(-753.6%) | -$7.00M(-41.0%) |
| Sep 1999 | - | $1.69M(+61.4%) | -$11.86M(+0.1%) |
| Jun 1999 | - | $1.05M(-19.5%) | -$11.85M(+16.2%) |
| Mar 1999 | - | $1.30M(-108.2%) | -$10.19M(-27.7%) |
| Dec 1998 | -$8.25M(-0.6%) | -$15.89M(-1034.8%) | -$14.09M(+18.4%) |
| Sep 1998 | - | $1.70M(-37.0%) | -$11.90M(-4.0%) |
| Jun 1998 | - | $2.70M(-203.8%) | -$12.40M(-10.1%) |
| Mar 1998 | - | -$2.60M(-81.0%) | -$13.80M(+51.6%) |
| Dec 1997 | -$8.30M(+2.5%) | -$13.70M(-1241.7%) | -$9.10M(+12.3%) |
| Sep 1997 | - | $1.20M(-7.7%) | -$8.10M(-5.8%) |
| Jun 1997 | - | $1.30M(-38.1%) | -$8.60M(-4.4%) |
| Mar 1997 | - | $2.10M(-116.5%) | -$9.00M(-25.0%) |
| Dec 1996 | -$8.10M | -$12.70M(-1914.3%) | -$12.00M(-1814.3%) |
| Sep 1996 | - | $700.00K(-22.2%) | $700.00K(>+9900.0%) |
| Jun 1996 | - | $900.00K(-200.0%) | $0.00(-100.0%) |
| Mar 1996 | - | -$900.00K | -$900.00K |
FAQ
- What is Avadel Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual EBITDA year-on-year change?
- What is Avadel Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Avadel Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM EBITDA year-on-year change?
What is Avadel Pharmaceuticals annual EBITDA?
The current annual EBITDA of AVDL is -$35.57M
What is the all time high annual EBITDA for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual EBITDA is $98.59M
What is Avadel Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AVDL annual EBITDA has changed by +$113.56M (+76.15%)
What is Avadel Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AVDL is -$1.78M
What is the all time high quarterly EBITDA for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly EBITDA is $39.92M
What is Avadel Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AVDL quarterly EBITDA has changed by +$22.34M (+92.62%)
What is Avadel Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AVDL is -$13.23M
What is the all time high TTM EBITDA for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM EBITDA is $123.11M
What is Avadel Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AVDL TTM EBITDA has changed by +$132.47M (+90.92%)